Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 16,657,000 | 16,112,000 | 15,775,000 | 14,631,000 | 15,962,000 |
| Cost of Goods | 4,080,000 | 3,745,000 | 3,540,000 | 3,912,000 | 4,264,000 |
| Gross Profit | 12,577,000 | 12,367,000 | 12,235,000 | 10,719,000 | 11,698,000 |
| Operating Expenses | 8,593,000 | 6,239,000 | 6,475,000 | 12,431,000 | 5,826,000 |
| Operating Income | 3,984,000 | 6,128,000 | 5,760,000 | -1,712,000 | 5,872,000 |
| Other Income | 106,000 | -122,000 | -90,000 | -334,000 | -252,000 |
| Pre-tax Income | 4,090,000 | 6,006,000 | 5,670,000 | -2,046,000 | 5,620,000 |
| Income Tax | 929,000 | 545,000 | 903,000 | -820,000 | 870,000 |
| Net Income Continuous | 3,161,000 | 5,461,000 | 4,767,000 | -1,226,000 | 4,750,000 |
| Minority Interests | 4,000 | 6,000 | 5,000 | N/A | 5,000 |
| Net Income | $3,157,000 | $5,455,000 | $4,762,000 | $-1,226,000 | $4,745,000 |
| EPS Basic Total Ops | 1.25 | 2.15 | 1.88 | -0.49 | 1.87 |
| EPS Basic Continuous Ops | 1.25 | 2.16 | 1.88 | -0.49 | 1.87 |
| EPS Diluted Total Ops | 1.24 | 2.14 | 1.87 | -0.48 | 1.86 |
| EPS Diluted Continuous Ops | 1.24 | 2.15 | 1.87 | -0.48 | 1.87 |
| EPS Diluted Before Non-Recurring Items | 1.57 | 2.28 | 2.07 | 0.03 | 2.13 |
| EBITDA(a) | $5,170,000 | $7,260,000 | $6,744,000 | $-748,000 | $6,886,000 |